Dyadic International Inc (DYAI)
1.63
+0.02
(+1.00%)
USD |
NASDAQ |
May 21, 16:00
1.75
+0.12
(+7.36%)
After-Hours: 16:49
Dyadic International Revenue (TTM): 2.255M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.255M |
| December 31, 2023 | 2.899M |
| September 30, 2023 | 2.956M |
| June 30, 2023 | 3.438M |
| March 31, 2023 | 3.260M |
| December 31, 2022 | 2.930M |
| September 30, 2022 | 2.500M |
| June 30, 2022 | 2.313M |
| March 31, 2022 | 2.592M |
| December 31, 2021 | 2.404M |
| September 30, 2021 | 2.436M |
| June 30, 2021 | 2.160M |
| March 31, 2021 | 1.747M |
| December 31, 2020 | 1.602M |
| September 30, 2020 | 1.689M |
| June 30, 2020 | 1.727M |
| March 31, 2020 | 1.594M |
| December 31, 2019 | 1.681M |
| September 30, 2019 | 1.935M |
| June 30, 2019 | 1.743M |
| March 31, 2019 | 1.514M |
| December 31, 2018 | 1.296M |
| September 30, 2018 | 0.7656M |
| June 30, 2018 | 0.7751M |
| March 31, 2018 | 0.8212M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.7584M |
| September 30, 2017 | 1.092M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 0.3453M |
| March 31, 2016 | 0.3562M |
| December 31, 2015 | 0.3075M |
| September 30, 2015 | 0.3897M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| March 31, 2014 | 17.64M |
| December 31, 2013 | 17.13M |
| September 30, 2013 | 15.54M |
| June 30, 2013 | 19.93M |
| March 31, 2013 | 15.37M |
| September 30, 2012 | 16.27M |
| June 30, 2012 | 17.96M |
| March 31, 2012 | 14.08M |
| December 31, 2006 | 15.38M |
| September 30, 2006 | 16.02M |
| June 30, 2006 | 15.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.594M
Minimum
Mar 2020
3.438M
Maximum
Jun 2023
2.293M
Average
2.284M
Median
Revenue (TTM) Benchmarks
| AIM ImmunoTech Inc | 0.193M |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 59.65M |
| Electromed Inc | 53.50M |
| Armata Pharmaceuticals Inc | -- |